Cargando…
Human thymopoiesis produces polyspecific CD8(+) α/β T cells responding to multiple viral antigens
T-cell receptors (TCRs) are formed by stochastic gene rearrangements, theoretically generating >10(19) sequences. They are selected during thymopoiesis, which releases a repertoire of about 10(8) unique TCRs per individual. How evolution shaped a process that produces TCRs that can effectively ha...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063231/ https://www.ncbi.nlm.nih.gov/pubmed/36995951 http://dx.doi.org/10.7554/eLife.81274 |
Sumario: | T-cell receptors (TCRs) are formed by stochastic gene rearrangements, theoretically generating >10(19) sequences. They are selected during thymopoiesis, which releases a repertoire of about 10(8) unique TCRs per individual. How evolution shaped a process that produces TCRs that can effectively handle a countless and evolving set of infectious agents is a central question of immunology. The paradigm is that a diverse enough repertoire of TCRs should always provide a proper, though rare, specificity for any given need. Expansion of such rare T cells would provide enough fighters for an effective immune response and enough antigen-experienced cells for memory. We show here that human thymopoiesis releases a large population of clustered CD8(+) T cells harboring α/β paired TCRs that (i) have high generation probabilities and (ii) a preferential usage of some V and J genes, (iii) which CDR3 are shared between individuals, and (iv) can each bind and be activated by multiple unrelated viral peptides, notably from EBV, CMV, and influenza. These polyspecific T cells may represent a first line of defense that is mobilized in response to infections before a more specific response subsequently ensures viral elimination. Our results support an evolutionary selection of polyspecific α/β TCRs for broad antiviral responses and heterologous immunity. |
---|